RPID: Gunggung utang perusahaan Rapid Micro Biosystems Inc.

Logo perusahaan publik Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems (RPID) is recognized as the benchmark in sterility automation for pharmaceuticals, enjoying the absolute trust of the world's largest drug manufacturers. The price history on the GURU.Markets platform demonstrates the asset's dynamics, where the individual debt metric is fixed at 0.02. Rapid Micro Biosystems is increasing the number of installed control systems through the strategic integration of its software with leading IT production management ecosystems.

Rapid Micro - Utang perusahaan RPID (periode 04.07.2022 - 28.10.2026)

Rincian metrik komprehensif lan analitis Rapid Micro Biosystems (RPID)

- rega lan prakiraan konsensus rega:
Bagan bursa rapidmicrobio.com|RPID - Prakiraan konsensus analis
- data kapitalisasi pasar:
Kapitalisasi pasar Rapid Micro|RPID - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Buku Siji Saham Rapid Micro Biosystems|RPID - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku rapidmicrobio.com|RPID - Aset Agregat Perusahaan
- data utang lan likuiditas:
Utang marang Modal Rapid Micro Biosystems|RPID - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal rapidmicrobio.com|RPID - Gunggung utang perusahaan|Utang marang modal buku Rapid Micro
Analisis komprehensif perusahaan:RPID Rapid Micro Biosystems Inc.
Sampel barang Rapid Micro Biosystems Inc.

Conservative capital requires absolute transparency regarding an issuer's debt sustainability. This indicator compares the business's current liabilities against industry benchmarks, eliminating information gaps between quarterly reports. For Rapid Micro Biosystems (RPID), debt capital serves as a tool for expanding automated microbial control across pharmaceutical plants. Investments in scaling the technological pipeline justify a temporary increase in liabilities. Assess the feasibility of such expenditures by analyzing the dynamics of the debt burden.

Pesaing wigati

Gunggung kewajiban utang perusahaan Abbott Corp. (ABT)|Gunggung utang perusahaan TMO (Thermo Fisher Scientific)|Gunggung utang perusahaan gehealthcare.com GEHC|Gunggung utang perusahaan MTD|WAT: Tanggungan utang total perusahaan|Utang perusahaan Techne Corporation|BRKR (Bruker BioSpin) - Utang agregat perusahaan|Utang perusahaan AZTA (Azenta, Inc.)|Utang kumulatif perusahaan VREX|SMLR (Semler Scientific) - Utang perusahaan|Gunggung kewajiban utang perusahaan Butterfly Network Inc BFLY|Gunggung utang perusahaan Mesa Labs Corp (MLAB)|Tanggungan utang kumulatif perusahaan Quantum-Si Corporation QSI|Gunggung utang perusahaan NNOX (Nano-X Imaging Ltd.)|QTRX - Gunggung kewajiban utang perusahaan|MASS (908 Devices) - Gunggung utang perusahaan|Gunggung utang perusahaan CapsoVision|MXCT - Gunggung utang perusahaan|Kewajiban utang agregat SEER|Utang perusahaan HYPR (Hyperfine, Inc.)|Gunggung utang perusahaan fonar.com (FONR)|DXR: Gunggung utang perusahaan|Utang kumulatif perusahaan spectral-ai.com MDAI|VivoSim Labs (VIVS) - Gunggung utang perusahaan|ACON - Utang agregat perusahaan|akoyabio.com - Gunggung utang perusahaan|thermogenesis.com (THMO) - Gunggung kewajiban utang perusahaan|Gunggung utang perusahaan TLIS|Gunggung utang perusahaan T2 Biosystems Inc.